1. Presurgical levels of circulating cell-derived microparticles discriminate between patients with and without transfusion in coronary artery bypass graft surgery 
Wenche Jy, PhD, Orlando Gómez-Marín, MSc, PhD, Tomas A. Salerno, MD, Anthony L. Panos, MD, Donald Williams, MD, Lawrence L. Horstman, BS, Yeon S. Ahn, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 149, Issue 1, Pages (January 2015)
DOI: /j.jtcvs
Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Scatter diagrams of probability of transfusion versus (A) HGB, (B) aPTT, (C) CD41+ PMP, and (D) CD235a+ RMP. HGB, Hemoglobin; aPTT, activated partial thromboplastin time; PMP, platelet-derived microparticle; RMP, red cell–derived microparticle; Tx, red blood cell transfusion(s) during and/or after surgery.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Comparison of ROC curve and AUC for CD41+ PMP, RMP, aPTT, HGB, and combined model. ROC, Receiver operating characteristic; AUC, area under the ROC curve; PMP, platelet-derived microparticle; RMP, red cell–derived microparticle; aPTT, activated partial thromboplastin time; HGB, hemoglobin.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions